Novartis to acquire Excellergy in deal worth up to $2bn
Exl-111, a potential treatment included in the deal, is a central factor in many allergic diseases
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Sandoz partners with Samsung Bioepis to develop up to five biosimilars
The agreement will expand the pipeline and builds on an existing partnership
Novartis to acquire Excellergy in deal worth up to $2bn
Exl-111, a potential treatment included in the deal, is a central factor in many allergic diseases
Novo Nordisk’s Awiqli approved by US FDA as once-weekly basal insulin for patients with type 2 diabetes
The insulin is designed as an alternative to daily basal insulin
Pistoia Alliance publishes first best-practice framework for ethical social media use in drug development
The Alliance calls for funding and expertise for the next phase of its social media project, marking its first direct engagement with oncology, rare disease and cardiology patients
Copenhagen Airports A/S, SAS Cargo and World Courier to host FlyPharma 2026
The conference will take place from 6 to 7 October 2026 in Copenhagen, Denmark
Latest content
Poolbeg Pharma appoints Adrian Kilcoyne to Scientific Advisory Board
Kilcoyne previously held senior roles at AstraZeneca, Celgene, Sanofi, Roche and Eli Lilly
Read More
Achieving comms excellence through personalised engagement
By Daniel Gibbs
Read More
Ipsen appoints Michelle Werner as Executive Vice President, President of North America
Werner previously held senior roles at Bristol Myers Squibb, AstraZeneca and Novartis
Read More
Intelligence
The digital age and the advance of AI – pushing communications to new heights
As new comms excellence opportunities abound, staying connected through core messaging remains critical
Read More
GenAI: embracing the transformation – with caution
Despite the GenAI fervour, there is an acute need to prepare organisations to understand which specific tools they need and how to use them
Read More
The race to explore and harness GenAI in healthcare
AI has graduated from being a procurer of efficiencies to seemingly an enabler of unimagined possibilities
Read More
Communication breakdown
Why soft skills are more important than ever in life sciences
Read More
Medicine shortages strike again – can radio-frequency identification technology help?
RFID has emerged as a key technology for its rapid, accurate data capture, and track and trace capabilities for manufacturing and supply chain operations
Read More
Pandemic readiness is now a financial risk test – and the UK must treat it that way
COVID-19 showed how quickly a health emergency becomes a fiscal event: disrupting supply chains, reshaping capital allocation and exposing governance weaknesses
Read More
Blogs
Latest
Insight gaps leave Biopharma vulnerable to patent cliff crisis, warns expert
April 1, 2026 | Nmblr|Patent cliffs; commercialisation strategy; innovation; biosimilars; biopharma;
With unprecedented patent cliffs looming, putting an estimated $200 to $400 billion in annual global sales at risk , senior strategy consultant and Nmblr founder, …
HRW Wins 2026 Artificial Intelligence Excellence Award in the Pharmaceutical Category
March 26, 2026 | Healthcare Research Worldwide|AI, Avatars, Innovation, artificial intelligence, market research
Healthcare Research Worldwide (HRW) has been named a winner in the 2026 Artificial Intelligence Excellence Awards in the Pharmaceutical category, recognizing its innovative use of …
Amiculum reaffirms presence in Dundee with new office and continued academic partnership
March 26, 2026 | Amiculum|Dundee, life sciences
Amiculum is pleased to announce the relocation of its Dundee team to a new, state-of-the-art facility at the Dundee Life Sciences Innovation Hub, an environment …
GRACE COMMS acquisition of WORDBIRD creates a merger of two independent, strategic and creative healthcare agencies
March 25, 2026 | Grace Communications|Agency news, Grace Communications, Wordbird, acquisition
We are delighted to announce that Grace Comms and Wordbird Limited, both healthcare brand comms agencies with a creative mission in healthcare and a passion …
Leading with Heart: Why Vulnerability is a Force Multiplier
March 20, 2026 | Medscape Education|#HearFromHer #UnconventionalLeadership
In a world that often prizes “macho” decisiveness, Dr. Lobna Salem (CMO at Viatris) and Dr. Amrit Ray (Board Chairman and former Pfizer executive) are …
From text to context: Helping patients see side effects clearly
March 30, 2026 | Cuttsy + Cuttsy|health information, health literacy, healthcare communications
Discover how thoughtful design, clear language, and structured visuals can transform overwhelming side effect information into accessible, actionable insights for patients in our latest Health …
Amiculum meets Paul Tunnah: Pharma’s adoption of AI in healthcare communications
March 26, 2026 | Amiculum|artificial intelligence
By Steve Wilson
Intelligent field team engagement: Turning shared knowledge into deeper insights and better decisions.
March 5, 2026 | Inizio|
At Age of AI 2026, Inizio Medical’s Phil Wakefield and Inizio Ignite’s Tim Luxford will explore how cross-functional collaboration and AI can unlock faster, more …
AI in practice: 4 real-world use cases in health and life sciences
March 5, 2026 | Inizio|
Artificial Intelligence (AI) is often discussed in broad terms, with promises of transformation at scale. In practice, however, its value is realized in far more …
A Pharma Brand Manager’s Guide to Exhibiting
March 5, 2026 | Apex Events and Exhibitions|Congress, exhibitions, exhibitionstanddesigners, exhibitionstands
Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what …